ORIC Pharmaceuticals, Inc. Share Price Börse Stuttgart
Equities
4TZ
US68622P1093
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.35 EUR | +8.44% | +4.38% | +2.45% |
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 606M 559M 47.57B |
---|---|---|---|---|---|
Net income 2024 * | -114M -105M -8.95B | Net income 2025 * | -139M -128M -10.91B | EV / Sales 2024 * | - |
Net cash position 2024 * | - 0 0 | Net cash position 2025 * | - 0 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-5.22
x | P/E ratio 2025 * |
-4.66
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 90.45% |
Latest transcript on ORIC Pharmaceuticals, Inc.
1 week | +4.38% | ||
3 months | -21.96% | ||
6 months | +20.14% | ||
Current year | +2.45% |
Managers | Title | Age | Since |
---|---|---|---|
Jacob Chacko
CEO | Chief Executive Officer | 45 | 06/05/18 |
Richard Heyman
FOU | Founder | 66 | 31/12/13 |
Director of Finance/CFO | 50 | 31/08/19 |
Members of the board | Title | Age | Since |
---|---|---|---|
Angie You
BRD | Director/Board Member | 51 | 08/11/21 |
Richard Heyman
FOU | Founder | 66 | 31/12/13 |
Mardi Dier
BRD | Director/Board Member | 60 | 01/03/20 |
Date | Price | Change |
---|---|---|
31/05/24 | 8.35 | +8.44% |
30/05/24 | 7.7 | -0.65% |
29/05/24 | 7.75 | -1.90% |
28/05/24 | 7.9 | +1.94% |
27/05/24 | 7.75 | -3.12% |
Delayed Quote Börse Stuttgart, May 31, 2024 at 04:56 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+11.91% | 118B | |
+11.60% | 106B | |
-4.68% | 24.28B | |
-0.82% | 21.96B | |
-10.12% | 18.16B | |
-42.12% | 16.37B | |
-17.47% | 15.56B | |
+2.77% | 13.63B | |
+34.58% | 12.27B |
- Stock Market
- Equities
- ORIC Stock
- 4TZ Stock